{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T19:15:50Z","timestamp":1795029350467,"version":"4.10.2"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":83,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2026JJ80979"],"award-info":[{"award-number":["2026JJ80979"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2023JJ30959"],"award-info":[{"award-number":["2023JJ30959"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473299"],"award-info":[{"award-number":["82473299"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04762-y","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T16:45:53Z","timestamp":1783010753000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Nano-hydrogel-based delivery system for dihydroartemisinin to enhance cuproptosis and synergize with anti-PD-1 therapy in triple-negative breast cancer"],"prefix":"10.1186","volume":"24","author":[{"given":"Qiaoli","family":"Yi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fada","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong-Fei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu-Gen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengyu","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangrui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaokang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanliang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"key":"4762_CR1","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.semcancer.2025.10.006","volume":"117","author":"F Xia","year":"2025","unstructured":"Xia F, Yi Q, Xu Z, Zhou Z, Tang H, Zhang K, Yan Y. Microbial modulation as a game changer: Boosting immunotherapy efficacy in breast cancer. Semin Cancer Biol. 2025;117:152\u201367.","journal-title":"Semin Cancer Biol"},{"key":"4762_CR2","doi-asserted-by":"publisher","first-page":"e18761429263063","DOI":"10.2174\/0118761429263063231204095516","volume":"17","author":"MH Pourhanifeh","year":"2024","unstructured":"Pourhanifeh MH, Farrokhi-Kebria H, Mostanadi P, Farkhondeh T, Samarghandian S. Anticancer Properties of Baicalin against Breast Cancer and other Gynecological Cancers: Therapeutic Opportunities based on Underlying Mechanisms. Curr Mol Pharmacol. 2024;17:e18761429263063.","journal-title":"Curr Mol Pharmacol"},{"key":"4762_CR3","first-page":"392","volume":"5","author":"Y Wang","year":"2025","unstructured":"Wang Y, Wang X, Wu J, Liu H, Zhao J, Huang J, Liu J, Gong Y, Wang H, Yang H, et al. Real-world effectiveness of goserelin 10.8-mg compared to goserelin 3.6-mg in premenopausal and perimenopausal Chinese patients with hormone receptor positive breast cancer: a cohort study. J Natl Cancer Cent. 2025;5:392\u2013401.","journal-title":"J Natl Cancer Cent"},{"key":"4762_CR4","doi-asserted-by":"publisher","first-page":"e18761429263841","DOI":"10.2174\/0118761429263841230926014118","volume":"17","author":"Y Naeimzadeh","year":"2024","unstructured":"Naeimzadeh Y, Heidari Z, Razban V, Khajeh S. Deregulated MicroRNAs involved in P53 Signaling Pathway in Breast Cancer with Focus on Triple-negative Breast Cancer. Curr Mol Pharmacol. 2024;17:e18761429263841.","journal-title":"Curr Mol Pharmacol"},{"key":"4762_CR5","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cpan.2025.12.005","volume":"22","author":"E Hu","year":"2026","unstructured":"Hu E, Wang Y, Chen G, Xu C, Liu S, Zou Y, Luo X, Gong Y. Trifluridine\/tipiracil exhibits potent antitumor activity in triple-negative breast cancer by targeting SKP2 and inducing cell cycle arrest and apoptosis. Curr Pharm Anal. 2026;22:35\u201343.","journal-title":"Curr Pharm Anal"},{"key":"4762_CR6","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1146\/annurev-pathol-042420-093238","volume":"17","author":"F Derakhshan","year":"2022","unstructured":"Derakhshan F, Reis-Filho JS. Pathogenesis of Triple-Negative Breast Cancer. Annu Rev Pathol. 2022;17:181\u2013204.","journal-title":"Annu Rev Pathol"},{"key":"4762_CR7","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3390\/medsci13040275","volume":"13","author":"K Girigoswami","year":"2025","unstructured":"Girigoswami K, Girigoswami A. Breast Cancer Progression and Its Theranostic Management via Folate-Directed Targeting of Glycoprotein Receptor. Med Sci. 2025;13:275.","journal-title":"Med Sci"},{"key":"4762_CR8","doi-asserted-by":"publisher","first-page":"218278","DOI":"10.1016\/j.canlet.2026.218278","volume":"641","author":"F Xia","year":"2026","unstructured":"Xia F, Zhu X, Li X, Yi Q, Zhou S, Wang J, Wang X, Zhang K, Zhan C, Tang H, et al. FIG4 downregulation-arrested autophagy-lysosomal degradation of IL-18 drives lipid-associated macrophage polarization and immunotherapy resistance in triple-negative breast cancer. Cancer Lett. 2026;641:218278.","journal-title":"Cancer Lett"},{"key":"4762_CR9","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1634\/theoncologist.2014-0002","volume":"19","author":"M Bonotto","year":"2014","unstructured":"Bonotto M, Gerratana L, Poletto E, Driol P, Giangreco M, Russo S, Minisini AM, Andreetta C, Mansutti M, Pisa FE, et al. Measures of outcome in metastatic breast cancer: insights from a real-world scenario. Oncologist. 2014;19:608\u201315.","journal-title":"Oncologist"},{"key":"4762_CR10","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1016\/S0140-6736(06)68931-9","volume":"367","author":"F Smithuis","year":"2006","unstructured":"Smithuis F, Kyaw MK, Phe O, Aye KZ, Htet L, Barends M, Lindegardh N, Singtoroj T, Ashley E, Lwin S, et al. Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison. Lancet. 2006;367:2075\u201385.","journal-title":"Lancet"},{"key":"4762_CR11","doi-asserted-by":"publisher","first-page":"216596","DOI":"10.1016\/j.canlet.2023.216596","volume":"582","author":"X Dai","year":"2024","unstructured":"Dai X, Chen W, Qiao Y, Chen X, Chen Y, Zhang K, Zhang Q, Duan X, Li X, Zhao J, et al. Dihydroartemisinin inhibits the development of colorectal cancer by GSK-3beta\/TCF7\/MMP9 pathway and synergies with capecitabine. Cancer Lett. 2024;582:216596.","journal-title":"Cancer Lett"},{"key":"4762_CR12","doi-asserted-by":"publisher","first-page":"603","DOI":"10.7150\/ijbs.50364","volume":"17","author":"X Dai","year":"2021","unstructured":"Dai X, Zhang X, Chen W, Chen Y, Zhang Q, Mo S, Lu J. Dihydroartemisinin: A Potential Natural Anticancer Drug. Int J Biol Sci. 2021;17:603\u201322.","journal-title":"Int J Biol Sci"},{"key":"4762_CR13","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1038\/s12276-025-01582-2","volume":"57","author":"JG Cho","year":"2025","unstructured":"Cho JG, Kim SW, Yun E, Yoon S, Choi J, Yeom D, Lee A, Lee D, Jeong SJ, Chang W, et al. Dihydroartemisinin inhibits metastatic potential and cancer stemness by modulating the miR-200b-BMI-1\/VEGF-A axis in ovarian cancer. Exp Mol Med. 2025;57:2782\u201397.","journal-title":"Exp Mol Med"},{"key":"4762_CR14","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/kjm2.12684","volume":"39","author":"XY Lai","year":"2023","unstructured":"Lai XY, Shi YM, Zhou MM. Dihydroartemisinin enhances gefitinib cytotoxicity against lung adenocarcinoma cells by inducing ROS-dependent apoptosis and ferroptosis. Kaohsiung J Med Sci. 2023;39:699\u2013709.","journal-title":"Kaohsiung J Med Sci"},{"key":"4762_CR15","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.2174\/1871520622666220215121341","volume":"22","author":"Q Zhou","year":"2022","unstructured":"Zhou Q, Ye F, Qiu J, Zhang S, Jiang Q, Xue D, Li J. Dihydroartemisinin Induces ER Stress-Mediated Apoptosis in Human Tongue Squamous Carcinoma by Regulating ROS Production. Anticancer Agents Med Chem. 2022;22:2902\u20138.","journal-title":"Anticancer Agents Med Chem"},{"key":"4762_CR16","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1111\/bcp.13372","volume":"83","author":"P Chotsiri","year":"2017","unstructured":"Chotsiri P, Wattanakul T, Hoglund RM, Hanboonkunupakarn B, Pukrittayakamee S, Blessborn D, Jittamala P, White NJ, Day NPJ, Tarning J. Population pharmacokinetics and electrocardiographic effects of dihydroartemisinin-piperaquine in healthy volunteers. Br J Clin Pharmacol. 2017;83:2752\u201366.","journal-title":"Br J Clin Pharmacol"},{"key":"4762_CR17","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/j.1365-2125.2011.04103.x","volume":"73","author":"R McGready","year":"2012","unstructured":"McGready R, Phyo AP, Rijken MJ, Tarning J, Lindegardh N, Hanpithakpon W, Than HH, Hlaing N, Zin NT, Singhasivanon P, et al. Artesunate\/dihydroartemisinin pharmacokinetics in acute falciparum malaria in pregnancy: absorption, bioavailability, disposition and disease effects. Br J Clin Pharmacol. 2012;73:467\u201377.","journal-title":"Br J Clin Pharmacol"},{"key":"4762_CR18","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s12951-023-01959-3","volume":"21","author":"Y Yan","year":"2023","unstructured":"Yan Y, Yang X, Han N, Liu Y, Liang Q, Li L-G, Hu J, Li T-F, Xu Z. Metal-organic framework-encapsulated dihydroartemisinin nanoparticles induces apoptotic cell death in ovarian cancer by blocking ROMO1-mediated ROS production. J Nanobiotechnol. 2023;21:204.","journal-title":"J Nanobiotechnol"},{"key":"4762_CR19","doi-asserted-by":"publisher","first-page":"147032032614262","DOI":"10.1177\/14703203261426211","volume":"27","author":"D Lu","year":"2026","unstructured":"Lu D, Li Y, Shi J, Yu S, Wang X, Liang X, Mei X, Wu J, Chen P, Huang Q, Liu D. Dulaglutide promotes mitophagy by regulating copper metabolism and protects retinal pigment epithelial cells from high glucose-induced damage. J Renin Angiotensin Aldosterone Syst. 2026;27:14703203261426211.","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"4762_CR20","doi-asserted-by":"publisher","first-page":"100228","DOI":"10.1016\/j.lddd.2025.100228","volume":"22","author":"X Chen","year":"2025","unstructured":"Chen X, Min Y, Xiao Y, Zhang Q, Zhang J. Identification of potential targets and mechanisms of Mahuang in treating allergic rhinitis via network pharmacology and bioinformatics. Lett Drug Des Discovery. 2025;22:100228.","journal-title":"Lett Drug Des Discovery"},{"key":"4762_CR21","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41392-025-02192-0","volume":"10","author":"Z Guo","year":"2025","unstructured":"Guo Z, Chen D, Yao L, Sun Y, Li D, Le J, Dian Y, Zeng F, Chen X, Deng G. The molecular mechanism and therapeutic landscape of copper and cuproptosis in cancer. Signal Transduct Target Ther. 2025;10:149.","journal-title":"Signal Transduct Target Ther"},{"key":"4762_CR22","first-page":"453","volume":"5","author":"H Zhang","year":"2025","unstructured":"Zhang H, Wang S, Wu P, Hu Z, Chen Y, Guan Y, Pang J. Revealing the landscape of targeting mitochondrial functions and behaviors to overcome cancer chemoresistance. J Natl Cancer Cent. 2025;5:453\u201373.","journal-title":"J Natl Cancer Cent"},{"key":"4762_CR23","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1186\/s12951-025-03722-2","volume":"23","author":"X Liang","year":"2025","unstructured":"Liang X, Fang S, Xin Y, Lei J, Wang W, Wei Y, Li W, Li C, Tang H, Wei X, et al. Cascade-targeting copper homeostasis nano-regulators for mild-photothermal boosted cuproptosis\/ferroptosis mediated breast cancer therapy. J Nanobiotechnol. 2025;23:651.","journal-title":"J Nanobiotechnol"},{"key":"4762_CR24","doi-asserted-by":"publisher","first-page":"e2304407","DOI":"10.1002\/smll.202304407","volume":"20","author":"J Zheng","year":"2024","unstructured":"Zheng J, Ge H, Guo M, Zhang T, Hu Q, Yao Q, Long S, Sun W, Fan J, Du J, Peng X. Photoinduced Cuproptosis with Tumor-Specific for Metastasis-Inhibited Cancer Therapy. Small. 2024;20:e2304407.","journal-title":"Small"},{"key":"4762_CR25","doi-asserted-by":"publisher","first-page":"23941","DOI":"10.1021\/acsnano.3c10588","volume":"18","author":"H Zu","year":"2024","unstructured":"Zu H, Wu Y, Meng H, Cheng X, Wang Y, Zhang LW, Wang Y. Tumor Metabolism Aiming Cu(2-x)S Nanoagents Mediate Photothermal-Derived Cuproptosis and Immune Activation. ACS Nano. 2024;18:23941\u201357.","journal-title":"ACS Nano"},{"key":"4762_CR26","doi-asserted-by":"publisher","first-page":"101098","DOI":"10.1016\/j.drup.2024.101098","volume":"75","author":"Z Xu","year":"2024","unstructured":"Xu Z, Zhou H, Li T, Yi Q, Thakur A, Zhang K, Ma X, Qin JJ, Yan Y. Application of biomimetic nanovaccines in cancer immunotherapy: A useful strategy to help combat immunotherapy resistance. Drug Resist Updat. 2024;75:101098.","journal-title":"Drug Resist Updat"},{"key":"4762_CR27","doi-asserted-by":"publisher","first-page":"107975","DOI":"10.1016\/j.phrs.2025.107975","volume":"221","author":"X Wang","year":"2025","unstructured":"Wang X, Wang C, Liu W, Thakur A, Zhang K, Xu Z, Li J. The roles of ultrasound-responsive nanomaterials in enhancing cancer immunotherapy. Pharmacol Res. 2025;221:107975.","journal-title":"Pharmacol Res"},{"key":"4762_CR28","doi-asserted-by":"publisher","first-page":"e23478","DOI":"10.1002\/adfm.202523478","volume":"36","author":"TMH Huynh","year":"2025","unstructured":"Huynh TMH, Tran NT, Lee YS, Chang YH, Iao HM, Pan WC, Lien HW, Chou TC, Chiang WH, Li SJ, et al. Dysfunctional T Cell Reprogramming via Cascade-Responsive Catalytic Nanosponges\u2010Mediated Tumor\u2010Specific Antigen Capture for Remote Glioblastoma Immunotherapy. Adv Funct Mater. 2025;36:e23478.","journal-title":"Adv Funct Mater"},{"key":"4762_CR29","doi-asserted-by":"publisher","first-page":"102197","DOI":"10.1016\/j.mtbio.2025.102197","volume":"34","author":"G Li","year":"2025","unstructured":"Li G, Li X, Lou Z, Xu J, Ma Y, Li X, Liu Q, Sun T. Recent advances in copper sulfide nanoparticles for cancer diagnosis and therapy. Mater Today Bio. 2025;34:102197.","journal-title":"Mater Today Bio"},{"key":"4762_CR30","doi-asserted-by":"publisher","first-page":"102468","DOI":"10.1016\/j.mtbio.2025.102468","volume":"35","author":"M Aili","year":"2025","unstructured":"Aili M, Lin F, Chen Y, Alifu N, Ma R, Chu C, Xiong J, Cui Y, Du Z, Ma C, et al. Overcoming chemoresistance via NO-mediated HSP inhibition using hybrid membrane-coated multifunctional nanoplatforms. Mater Today Bio. 2025;35:102468.","journal-title":"Mater Today Bio"},{"key":"4762_CR31","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1039\/D4TB02125H","volume":"13","author":"X Zhang","year":"2025","unstructured":"Zhang X, Shi C, Liu Q, Zhong Y, Zhu L, Zhao Y. Combination of adenosine blockade and ferroptosis for photo-immunotherapy of triple negative breast cancer with aptamer-modified copper sulfide. J Mater Chem B. 2025;13:2504\u201319.","journal-title":"J Mater Chem B"},{"key":"4762_CR32","doi-asserted-by":"publisher","first-page":"24456","DOI":"10.1080\/19443994.2016.1138896","volume":"57","author":"M Ghaedi","year":"2016","unstructured":"Ghaedi M, Yousefi-Nejad M, Safarpoor M, Khafri HZ, Tyagi I, Agarwal S, Gupta VK. Synthesis of CuS nanoparticles and evaluation of its antimicrobial properties in combination with Linum usitatissimum root and shoot extract. Desalination Water Treat. 2016;57:24456\u201366.","journal-title":"Desalination Water Treat"},{"key":"4762_CR33","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s13020-025-01259-y","volume":"20","author":"Q Yi","year":"2025","unstructured":"Yi Q, Chen X, Zhou S, Wang J, Yan Y. Corynoline enhances sorafenib sensitivity in hepatocellular carcinoma via NOS3-mediated ROS production. Chin Med. 2025;20:189.","journal-title":"Chin Med"},{"key":"4762_CR34","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1186\/s12951-024-02694-z","volume":"22","author":"Z Xu","year":"2024","unstructured":"Xu Z, Zhou Z, Yang X, Thakur A, Han N, Li H-T, Li L-G, Hu J, Li T-f, Yan Y. Determining M2 macrophages content for the anti-tumor effects of metal-organic framework-encapsulated pazopanib nanoparticles in breast cancer. J Nanobiotechnol. 2024;22:429.","journal-title":"J Nanobiotechnol"},{"key":"4762_CR35","doi-asserted-by":"publisher","first-page":"e02817","DOI":"10.1002\/adhm.202502817","volume":"15","author":"HW Lien","year":"2025","unstructured":"Lien HW, Kuo YY, Chang YH, Huynh TMH, Yalamandala BN, Li TC, Iao HM, Pan WC, Lee AYL, Chiang WH, Hu SH. Electromagnetic Wireless Remote Control of Reprogramming Immune Dysfunction via N-Doped Carbon Dots\u2013Mesoporous Silica\u2010Mediated Cuproptosis and Dendritic Cell Retention. Adv Healthc Mater. 2025;15:e02817.","journal-title":"Adv Healthc Mater"},{"key":"4762_CR36","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.ccell.2025.03.031","volume":"43","author":"G Lei","year":"2025","unstructured":"Lei G, Sun M, Cheng J, Ye R, Lu Z, Horbath A, Huo D, Wu S, Alapati A, Aggarwal S, et al. Radiotherapy promotes cuproptosis and synergizes with cuproptosis inducers to overcome tumor radioresistance. Cancer Cell. 2025;43:1076\u2013e10921075.","journal-title":"Cancer Cell"},{"key":"4762_CR37","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.abf0529","volume":"375","author":"P Tsvetkov","year":"2022","unstructured":"Tsvetkov P, Coy S, Petrova B, Dreishpoon M, Verma A, Abdusamad M, Rossen J, Joesch-Cohen L, Humeidi R, Spangler RD, et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science. 2022;375:1254\u201361.","journal-title":"Science"},{"key":"4762_CR38","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1021\/acsnano.4c09525","volume":"19","author":"M-R Chiang","year":"2024","unstructured":"Chiang M-R, Hsu C-W, Pan W-C, Tran N-T, Lee Y-S, Chiang W-H, Liu Y-C, Chen Y-W, Chiou S-H, Hu S-H. Reprogramming Dysfunctional Dendritic Cells by a Versatile Catalytic Dual Oxide Antigen-Captured Nanosponge for Remotely Enhancing Lung Metastasis Immunotherapy. ACS Nano. 2024;19:2117\u201335.","journal-title":"ACS Nano"},{"key":"4762_CR39","doi-asserted-by":"publisher","first-page":"25134","DOI":"10.1021\/acsnano.5c05395","volume":"19","author":"TMH Huynh","year":"2025","unstructured":"Huynh TMH, Huang P-X, Wang K-L, Tran N-T, Iao HM, Pan W-C, Chang Y-H, Lien H-W, Lee AY-L, Chou T-C, et al. Reprogramming Immunodeficiency in Lung Metastases via PD-L1 siRNA Delivery and Antigen Capture of Nanosponge-Mediated Dendritic Cell Modulation. ACS Nano. 2025;19:25134\u201353.","journal-title":"ACS Nano"},{"key":"4762_CR40","doi-asserted-by":"publisher","first-page":"154682","DOI":"10.1016\/j.phymed.2023.154682","volume":"112","author":"N Han","year":"2023","unstructured":"Han N, Yang ZY, Xie ZX, Xu HZ, Yu TT, Li QR, Li LG, Peng XC, Yang XX, Hu J, et al. Dihydroartemisinin elicits immunogenic death through ferroptosis-triggered ER stress and DNA damage for lung cancer immunotherapy. Phytomedicine. 2023;112:154682.","journal-title":"Phytomedicine"},{"key":"4762_CR41","doi-asserted-by":"publisher","first-page":"112637","DOI":"10.1016\/j.intimp.2024.112637","volume":"139","author":"Z Zhou","year":"2024","unstructured":"Zhou Z, Lei J, Fang J, Chen P, Zhou J, Wang H, Sun Z, Chen Y, Yin L. Dihydroartemisinin remodels tumor micro-environment and improves cancer immunotherapy through inhibiting cyclin-dependent kinases. Int Immunopharmacol. 2024;139:112637.","journal-title":"Int Immunopharmacol"},{"key":"4762_CR42","doi-asserted-by":"publisher","first-page":"108702","DOI":"10.1016\/j.isci.2023.108702","volume":"27","author":"HY Zhao","year":"2024","unstructured":"Zhao HY, Li KH, Wang DD, Zhang ZL, Xu ZJ, Qi MH, Huang SW. A mitochondria-targeting dihydroartemisinin derivative as a reactive oxygen species -based immunogenic cell death inducer. iScience. 2024;27:108702.","journal-title":"iScience"},{"key":"4762_CR43","doi-asserted-by":"publisher","first-page":"975","DOI":"10.2147\/IJN.S68861","volume":"10","author":"G Bozzuto","year":"2015","unstructured":"Bozzuto G, Molinari A. Liposomes as nanomedical devices. Int J Nanomed. 2015;10:975\u201399.","journal-title":"Int J Nanomed"},{"key":"4762_CR44","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.addr.2012.09.037","volume":"65","author":"TM Allen","year":"2013","unstructured":"Allen TM, Cullis PR. Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev. 2013;65:36\u201348.","journal-title":"Adv Drug Deliv Rev"},{"key":"4762_CR45","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.colsurfb.2013.12.019","volume":"116","author":"C Righeschi","year":"2014","unstructured":"Righeschi C, Coronnello M, Mastrantoni A, Isacchi B, Bergonzi MC, Mini E, Bilia AR. Strategy to provide a useful solution to effective delivery of dihydroartemisinin: development, characterization and in vitro studies of liposomal formulations. Colloids Surf B Biointerfaces. 2014;116:121\u20137.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"4762_CR46","first-page":"475","volume":"17","author":"KH Wong","year":"2022","unstructured":"Wong KH, Yang D, Chen S, He C, Chen M. Development of nanoscale drug delivery systems of dihydroartemisinin for cancer therapy: A review. Asian J Pharm Sci. 2022;17:475\u201390.","journal-title":"Asian J Pharm Sci"},{"key":"4762_CR47","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1039\/C9BM00139E","volume":"7","author":"F Raza","year":"2019","unstructured":"Raza F, Zhu Y, Chen L, You X, Zhang J, Khan A, Khan MW, Hasnat M, Zafar H, Wu J, Ge L. Paclitaxel-loaded pH responsive hydrogel based on self-assembled peptides for tumor targeting. Biomaterials Sci. 2019;7:2023\u201336.","journal-title":"Biomaterials Sci"},{"key":"4762_CR48","doi-asserted-by":"crossref","unstructured":"Qi X, Zhang Z, Xi J, Cheng L, Li Y, Yang Q, Sun Z, Zhao T, Li X. Self-assembled hydrogels based on natural active ingredients: mechanisms, applications and characterization. J Mater Chem B. 2026;14:5184\u2013211.","DOI":"10.1039\/D6TB00104A"},{"key":"4762_CR49","doi-asserted-by":"publisher","first-page":"124220","DOI":"10.1016\/j.biomaterials.2026.124220","volume":"333","author":"Y Liu","year":"2026","unstructured":"Liu Y, Zhou X, Li W, Feng B, Sun J, Li R, Ma H, Li L, Zhou F, Ding J, Chen X. Ionic immune checkpoint blockade through potassium-scavenging hydrogel to potentiate CD8\u2009+\u2009T cell-mediated cancer immunotherapy. Biomaterials. 2026;333:124220.","journal-title":"Biomaterials"},{"key":"4762_CR50","doi-asserted-by":"crossref","unstructured":"Cai K, Xia R, Xu M, Chen W, Cai W, Liu X, Guo T, Jiang W, Yu C, Feng J et al. MnUA\u2013DOX\u2013artesunate hydrogel remodels immunosuppressive tumor microenvironment and prevents postoperative recurrence in triple-negative breast cancer. J Nanobiotechno. 2026;24:511.","DOI":"10.1186\/s12951-026-04381-7"},{"key":"4762_CR51","doi-asserted-by":"publisher","first-page":"5196","DOI":"10.1038\/srep05196","volume":"4","author":"J He","year":"2014","unstructured":"He J, Sinues PM-L, Hollm\u00e9n M, Li X, Detmar M, Zenobi R. Fingerprinting Breast Cancer vs. Normal Mammary Cells by Mass Spectrometric Analysis of Volatiles. Sci Rep. 2014;4:5196.","journal-title":"Sci Rep"},{"key":"4762_CR52","doi-asserted-by":"publisher","first-page":"1000165","DOI":"10.4172\/2157-2518.1000165","volume":"05","author":"YY Wei Dai","year":"2014","unstructured":"Wei Dai YY. Genomic Instability and Cancer. J Carcinog Mutagen. 2014;05:1000165.","journal-title":"J Carcinog Mutagen"},{"key":"4762_CR53","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/s41392-022-01229-y","volume":"7","author":"L Chen","year":"2022","unstructured":"Chen L, Min J, Wang F. Copper homeostasis and cuproptosis in health and disease. Signal Transduct Target Ther. 2022;7:378.","journal-title":"Signal Transduct Target Ther"},{"key":"4762_CR54","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13045-024-01589-8","volume":"17","author":"C Zhang","year":"2024","unstructured":"Zhang C, Huang T, Li L. Targeting cuproptosis for cancer therapy: mechanistic insights and clinical perspectives. J Hematol Oncol. 2024;17:68.","journal-title":"J Hematol Oncol"},{"key":"4762_CR55","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1039\/C6MT00076B","volume":"8","author":"KM Bompiani","year":"2016","unstructured":"Bompiani KM, Tsai C-Y, Achatz FP, Liebig JK, Howell SB. Copper transporters and chaperones CTR1, CTR2, ATOX1, and CCS as determinants of cisplatin sensitivity. Metallomics. 2016;8:951\u201362.","journal-title":"Metallomics"},{"key":"4762_CR56","doi-asserted-by":"publisher","first-page":"e2308241","DOI":"10.1002\/adma.202308241","volume":"36","author":"L Qiao","year":"2024","unstructured":"Qiao L, Zhu G, Jiang T, Qian Y, Sun Q, Zhao G, Gao H, Li C. Self-Destructive Copper Carriers Induce Pyroptosis and Cuproptosis for Efficient Tumor Immunotherapy Against Dormant and Recurrent Tumors. Adv Mater. 2024;36:e2308241.","journal-title":"Adv Mater"},{"key":"4762_CR57","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.biomaterials.2015.05.036","volume":"62","author":"L Liu","year":"2015","unstructured":"Liu L, Wei Y, Zhai S, Chen Q, Xing D. Dihydroartemisinin and transferrin dual-dressed nano-graphene oxide for a pH-triggered chemotherapy. Biomaterials. 2015;62:35\u201346.","journal-title":"Biomaterials"},{"key":"4762_CR58","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12951-022-01455-0","volume":"20","author":"XX Yang","year":"2022","unstructured":"Yang XX, Xu X, Wang MF, Xu HZ, Peng XC, Han N, Yu TT, Li LG, Li QR, Chen X, et al. A nanoreactor boosts chemodynamic therapy and ferroptosis for synergistic cancer therapy using molecular amplifier dihydroartemisinin. J Nanobiotechnol. 2022;20:230.","journal-title":"J Nanobiotechnol"},{"key":"4762_CR59","doi-asserted-by":"publisher","first-page":"123930","DOI":"10.1016\/j.biomaterials.2025.123930","volume":"329","author":"J Cai","year":"2026","unstructured":"Cai J, Shi S, Hu J, Zhang Z, Geng B, Pan D, Shen L. A stimuli-responsive cuproptosis switch boosts persistent immunotherapy for tumor eradication. Biomaterials. 2026;329:123930.","journal-title":"Biomaterials"},{"key":"4762_CR60","doi-asserted-by":"crossref","unstructured":"Li M, Zhang X, Li W, Zhang Y, Yuan B, Tian H, Zhang D, Liu Z, Fu X. Copper-based metal-polyphenol network encapsulated mesoporous silica for targeted cuproptosis induction and immunotherapy in melanoma. ACS Appl Mater Interf. 2026;18:21529\u201342.","DOI":"10.1021\/acsami.5c25538"},{"key":"4762_CR61","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.2174\/0113816128270290231029161741","volume":"29","author":"A Girigoswami","year":"2023","unstructured":"Girigoswami A, Adhikesavan H, Mudenkattil S, Devi S, Girigoswami K. Role of Cerium Oxide Nanoparticles and Doxorubicin in Improving Cancer Management: A Mini Review. Curr Pharm Design. 2023;29:2640\u201354.","journal-title":"Curr Pharm Design"},{"key":"4762_CR62","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s00210-024-03321-2","volume":"398","author":"P Pallavi","year":"2024","unstructured":"Pallavi P, Girigoswami K, Harini K, Gowtham P, Thirumalai A, Girigoswami A. Theranostic dye entrapped in an optimized blended-polymer matrix for effective photodynamic inactivation of diseased cells. Naunyn Schmiedebergs Arch Pharmacol. 2024;398:867\u201380.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04762-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04762-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04762-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:02:26Z","timestamp":1790164946000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04762-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4762"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04762-y","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,2]]},"assertion":[{"value":"7 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"893"}}